ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES

Optune® is an FDA-approved portable medical device that delivers continuous treatment with Tumor-Treating Fields (TTFields) to the supratentorial region of the brain and is indicated for the treatment of newly diagnosed glioblastoma multiforme (GBM) in combination with temozolomide and for recurrent...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Potter, Wyatt, Shah, Bimal, Shackelford, Melissa, Davis, Joe, Boatwright, Charles, Certo, Jeanine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691920/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak